Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUO-BREAST: ICG for Sentinel Node Detection
NCT02875626Completed
- Sponsor
- ARTIC
- Start
- Sep 2016
- Primary completion
- Feb 2019
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
Open-label, single-arm trial of Infracyanine in breast cancer, sponsored by ARTIC. Primary endpoint: Sentinel Node Detection Rate. Started Sep 2016; status: completed.
02
Drugs
Infracyanine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02875626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02875626.